Amgen Ventures LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Amgen Ventures LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Amgen Ventures LLC. Amgen Ventures LLC is a 10% Owner in AMGEN INC ($AMGN) and a 10% Owner in Epizyme, Inc. ($EPZM).

Address: ONE AMGEN CENTER DRIVE THOUSAND OAKS 91320-1799 CA

Companies in which Amgen Ventures LLC is an Insider

AMGEN INC

Trading Symbol: AMGN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Amgen Ventures LLC: 10% Owner
Holdings: 334,126 shares
Current Value: $55,738,899
Latest Transaction: Jun 05 2013
$AMGN Market Capitalization: $124.07B
$AMGN Previous Close: $166.82

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Epizyme, Inc.

Trading Symbol: EPZM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amgen Ventures LLC: 10% Owner
Holdings: 334,126 shares
Current Value: $4,026,218
Latest Transaction: Jun 05 2013
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Amgen Ventures LLC

Sentiment: All, AMGN, EPZM

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 05 2013EPZMEpizyme, Inc.Amgen Ventures LLC10% OwnerOption ExerciseC0.00952,38100
Jun 05 2013EPZMEpizyme, Inc.Amgen Ventures LLC10% OwnerBuyP15.0016,666249,990334,126317.5 K to 334.1 K (+5.25 %)
Jun 05 2013EPZMEpizyme, Inc.Amgen Ventures LLC10% OwnerBuyC0.00317,4600317,4600 to 317.5 K
Jun 05 2013AMGNAMGEN INCAmgen Ventures LLC10% OwnerOption ExerciseC0.00952,38100
Jun 05 2013AMGNAMGEN INCAmgen Ventures LLC10% OwnerBuyP15.0016,666249,990334,126317.5 K to 334.1 K (+5.25 %)
Jun 05 2013AMGNAMGEN INCAmgen Ventures LLC10% OwnerBuyC0.00317,4600317,4600 to 317.5 K

View all Amgen Ventures LLC insider transactions.